discussion on trial investigating erdafitinib in patients with urothelial cancer
Published 6 years ago • 377 plays • Length 3:02Download video MP4
Download video MP3
Similar videos
-
0:55
targeted therapy option of erdafitinib in bladder cancer #oncology #cancer #2023
-
7:18
case 3: experience with fgfr-targeted therapies in bladder cancer
-
1:54
dr. siefker-radtke on the phase ii study of erdafitinib in patients with urothelial carcinoma
-
2:20
the role of erdafitinib in treating patients with bladder cancer
-
5:24
case 3: fgfr-targeted therapy adverse events in bladder cancer
-
1:29:54
examining the state of the science on new therapies in bladder cancer
-
1:04
treatment considerations for patients with metastatic urothelial carcinoma
-
1:22
key clinical trials in urothelial carcinoma at esmo 2021
-
1:08
dr. rafii on durvaluamb in patients with urothelial bladder cancer
-
11:35
update on first biomarker-directed trial of non-muscle-invasive bladder cancer
-
4:47
asco 2023 highlights on erdafitinib in metastatic urothelial cancer with select fgfr alterations
-
2:21
dr. iyer on traes with erdafitinib in urothelial cancer
-
1:47
current and upcoming clinical trials in bladder cancer
-
14:16
new emerging treatment options and targeted therapies for bladder cancer
-
31:06
bladder cancer | 2022 oneoncology conference
-
27:14
metastatic bladder cancer: current practice and latest data from asco 2019
-
7:25
fgfr inhibitor clinical trials
-
16:37
state of the art lecture - developments in metastatic urothelial cancer